Xinrui Shao

468 citations
6 papers · 402 indexed · 1 hit paper · h-index 3
Topics
IL-33, ST2, and ILC Pathways (1 paper)Systemic Lupus Erythematosus Research (1 paper)Cancer-related gene regulation (1 paper)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Xinrui Shao

5 papers receiving 395 citations

Hit Papers

The microRNA miR-23b suppresses IL-17-associated autoimmu...20122026201620212012100200300

Peers

Xinrui Shao
Comparison fields: 5 of 76
  • Cancer Research 212
  • Molecular Biology 205
  • Immunology 137
  • Rheumatology 60
  • Oncology 46
Replace Yang Jia with:
Yang Jia China
Katarzyna Smigielska‐Czepiel Netherlands
Lian‐Ju Li China
Jake A. Kloeber United States
Ann-Christin Frank Germany
Rachel L. Morgan United States
Siobhán Smith Ireland
Saibyasachi N. Choudhury United States
Ray A. Ohara United States
Muyao Guo China
Xinrui Shao relative to Yang Jia China Yang Jia's profile →
Citations per field
00.5×
Yang Jia · 1×
Citations per year

Countries citing papers authored by Xinrui Shao

Since Specialization
Citations

This map shows the geographic impact of Xinrui Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinrui Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinrui Shao more than expected).

Fields of papers citing papers by Xinrui Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinrui Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinrui Shao. The network helps show where Xinrui Shao may publish in the future.

Co-authorship network of co-authors of Xinrui Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Xinrui Shao. A scholar is included among the top collaborators of Xinrui Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinrui Shao. Xinrui Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 1
5 29
6
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-αbreakdown →
369

About Xinrui Shao

Xinrui Shao is a scholar working on Business and International Management, Rheumatology and Hematology, having authored 6 papers that have together received 402 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (1 paper), Systemic Lupus Erythematosus Research (1 paper) and Cancer-related gene regulation (1 paper). The work is most often cited by research in Cancer Research (212 citations), Immunology (137 citations) and Rheumatology (60 citations). Xinrui Shao has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Youcun Qian, Xinyang Song, Nan Shen, Wen Pan, Dong Liang, Wenjun Liu, Honglin Wang, Yan Liu, Yuanjia Tang and Shu Zhu. Their work appears in journals such as Nature Medicine, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026